News – Page 990 – Endpoints News

UCB, Biogen admit defeat in PhII lupus trial, adding to a string of late-stage failures in the field

7 years ago

Enterome fortifies Takeda relationship with $50M upfront to co-develop Crohn's drug

7 years ago

AstraZeneca is paying Innate Pharma at least $242M in near-term cash to sew up rights to monalizumab-plus

7 years ago

Rattled by setbacks, Celgene turns to ex-Merck R&D star Alise Reicin to repair its damaged development rep

7 years ago

In key endorsement, Deerfield reserves $65M for drug venture with UNC-Chapel Hill

7 years ago

Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline

7 years ago

Dupixent wins FDA OK for asthma; Seres poaches new CMO from AstraZeneca

7 years ago

#ESMO18: Novartis claims a key win in breast cancer with PI3K drug alpelisib

7 years ago

Fidelity, Valor pool $71.8M for Jeff Aronin's plan to reformulate a generic for butterfly skin disease at Castle ...

7 years ago

Winners and losers at #ESMO18

7 years ago

One of Hal Barron's top drug prospects at GSK flunks a PhII test for rheumatoid arthritis, flailing in an intensely ...

7 years ago

Chipping away at Gilead's HIV empire, GSK's ViiV submits NDA for 2-drug HIV regimen -- playing voucher card for ...

7 years ago

TP Therapeutics grabs $80M mezzanine round to fund a pivotal trial for ROS-1/NTRK-positive cancers

7 years ago

#ESMO18: Cardio dreams blighted, Novartis showcases its “blockbuster” ambitions for radiopharmaceuticals

7 years ago

Merrimack Pharma’s stock plunges (again) on its latest cancer drug trial flop

7 years ago

#ESMO18: Crowned with a breakthrough title, Clovis takes an early lead as it races for a fast OK for Rubraca in ...

7 years ago

Merck previews an early hit with Keytruda combo for kidney cancer, putting more pressure on rival Bristol-Myers

7 years ago

Medivir taps ex-Acadia chief Uli Hacksell as interim CEO; Merck onboards chief digital officer

7 years ago

Proteostasis shares zoom north as their cystic fibrosis doublet causes a stir in small study -- triggering an online ...

7 years ago

FDA offers a proposal to help generic drug developers get simultaneous approvals in multiple markets

7 years ago

Takeda gets Japanese antitrust regulators' blessing for Shire deal; France's Acticor Biotech raises €15.3M for ...

7 years ago

Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T

7 years ago

Biotech vets launch a neuro startup with $54.5M to kickstart R&D

7 years ago

Amgen sharpens focus on genetic sequencing with $66M investment

7 years ago

First page Previous page 987 988 989990991 992 993 Next page Last page